Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties.
about
Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptorRole of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis.ACTH promotes chondrogenic nodule formation and induces transient elevations in intracellular calcium in rat bone marrow cell cultures via MC2-R signalingMultivariate heredity of melanin-based coloration, body mass and immunityMapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis.Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3Resolution of inflammation: targeting GPCRs that interact with lipids and peptides.How Factors Involved in the Resolution of Crystal-Induced Inflammation Target IL-1β.The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R).
P2860
Q24649952-2AD084BC-2061-493F-A8A4-282DF6990B56Q36134548-4226DA15-B954-4BC2-A804-622D6847194AQ36170863-A523096A-1EF6-4DEE-9BBF-103234752424Q36361763-1228E9C2-C8B6-4F18-8F5D-65D1C832E768Q36395186-F649D0ED-DBA1-410D-A592-63641C32A8BFQ36807768-BE85A2C5-34B2-4152-A8FE-1902F89423DAQ37026914-CDEC10A8-131C-4B18-A594-20096F62DADFQ37098469-5135069B-9B69-4184-8D9D-FA2A0054C686Q37694324-564AFC7E-B9D9-46A9-A159-4DF6BA8CE2B6Q38226022-0595879B-E425-4056-8FCB-758220A5453CQ39236078-C93A5743-A93F-426F-A2E4-7811C4C2B937Q40457702-E6F9499E-7454-4C7B-ABD6-8568BEC13176
P2860
Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Natural and synthetic agonists ...... anti-inflammatory properties.
@ast
Natural and synthetic agonists ...... anti-inflammatory properties.
@en
type
label
Natural and synthetic agonists ...... anti-inflammatory properties.
@ast
Natural and synthetic agonists ...... anti-inflammatory properties.
@en
prefLabel
Natural and synthetic agonists ...... anti-inflammatory properties.
@ast
Natural and synthetic agonists ...... anti-inflammatory properties.
@en
P2093
P1476
Natural and synthetic agonists ...... s anti-inflammatory properties
@en
P2093
P304
P577
2001-01-01T00:00:00Z